Novartis is stepping on the cGAS. Three years after securing an option on an IFM Therapeutics subsidiary, the Swiss drugmaker has accelerated into the deal and paid $90 million upfront for small ...
AustralianSuper and IFM Investors have agreed to pay A$16.2 billion ($12.3 billion) to the Australian state of New South Wales for a 99-year lease on the state's Ausgrid electricity distribution ...
Novartis is handing over $310 million up front to acquire IFM Therapeutics’ inflammation-centered subsidiary, IFM Tre. The deal includes up to $1.265 billion in milestones and gives Novartis access to ...
Investment firm InfraVia Capital Partners is to sell Swiss data center firm Green to IFM Investors. InfraVia this week announced IFM Global Infrastructure Fund (IFM GIF), advised by IFM Investors, has ...
IFM Therapeutics LLC, an innate immunity specialist that's quickly sparked major deals with big pharma, is stoking the generative fire at its heart with $55.5 million in new financing led by ...
HOUSTON--(BUSINESS WIRE)-- IFM Investors (“IFM”) today announced the formation of Mobius Renewables (the “Company”), a new global, vertically integrated low carbon fuels platform established to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results